Biocept Company

Biocept employs cell separation technology to develop a class of diagnostic assays for the early detection and diagnosis of cancer.
Technology: Сancer Diagnostics
Industry: Deep Diagnostics
Headquarters: San Diego, California, United States
Founded Date: 01.01.1993
Employees Number: 51-100
Funding Status: IPO
Investors Number: 3
Total Funding: $43.2M
Estimated Revenue: $1M to $10M
Last Funding Type: Post-IPO Equity

Visit Website
Register and Claim Ownership